Patent details

Basic Information

Publication number:

EP2814469

PCT Application Number:

GB2013050311

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP137094991

PCT Publication Number:

WO2013121184

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

HYDROCORTISONE CONTROLLED RELEASE FORMULATION

French Title of Invention:

PRÉPARATION À LIBÉRATION CONTRÔLÉE D'HYDROCORTISONE

German Title of Invention:

HYDROCORTISONFORMULIERUNG MIT KONTROLLIERTER FREISETZUNG

SPC Number:

Dates

Filing date:

12/02/2013

Grant date:

08/04/2020

EP Publication Date:

24/12/2014

PCT Publication Date:

22/08/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/04/2020

EP B1 Publication Date:

08/04/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

12/02/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/01/2025

 

 

Name:

NEUROCRINE UK LIMITED

Address:

Cardiff Medicentre Heath Park, CF14 4UJ, Cardiff, Glamorgan , United Kingdom (GB)

History of Owners

From:

01/04/2020

To:

31/01/2025

Name:

Diurnal Limited

Address:

Cardiff MediCentre, Heath Park Cardiff CF14 4UJ, United Kingdom (GB)

Agent

Name:

NOVAGRAAF BREVETS

From:

04/05/2020

Address:

BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)

To:

Inventor

1

Name:

HUATAN, Hiep

Address:

United Kingdom (GB)

2

Name:

ROSS, Richard

Address:

United Kingdom (GB)

3

Name:

WHITAKER, Martin

Address:

United Kingdom (GB)

Priority

1

Priority Number:

201202433

Priority Date:

13/02/2012

Priority Country:

United Kingdom (GB)

2

Priority Number:

201261599704 P

Priority Date:

16/02/2012

Priority Country:

United States (US)

3

Priority Number:

201261600958 P

Priority Date:

20/02/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/50; A61K 31/573;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2025/02

Publication date:

06/02/2025

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:

202015

Publication date:

08/04/2020

Description:

Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20250000041A

Date Registered:

31/01/2025

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

NEUROCRINE UK LIMITED

Address:

Cardiff Medicentre Heath Park, CF14 4UJ, Cardiff, Glamorgan , United Kingdom (GB)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

01/03/2027

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

27/02/2026

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages
31/01/2025	Request For Change	1
31/01/2025	Outgoing Correspondence	1
04/05/2020	Outgoing Correspondence	1
04/05/2020	Power Of Attorney	2